Medicare Enrolled

Dr. Utpal Bhanja, MD

Hematology & Oncology · Gallipolis, OH
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
170 JACKSON PIKE, Gallipolis, OH 45631
8554465937
In practice since 2005 (20 years)
NPI: 1003801689 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Bhanja from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bhanja? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Bhanja

Dr. Utpal Bhanja is a hematology & oncology specialist in Gallipolis, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. Bhanja performed 109 Medicare services across 104 unique beneficiaries.

Between the years covered by Open Payments, Dr. Bhanja received a total of $4,766 from 52 pharmaceutical and/or device companies across 234 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Bhanja is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 109 Medicare services $4,766 industry payments

Medicare Practice Summary

Medicare Utilization ↗
109
Medicare services
Bottom 7% in OH for hematology & oncology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
104
Unique beneficiaries
$99
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~5 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
48 $81 $161
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
17 $128 $274
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
16 $120 $269
New patient office visit, complex (60-74 min) 16 $139 $448
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
12 $49 $116
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$4,766
Total received (2018-2024)
Avg $681/year across 7 years
Top 40% in OH for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
52
Companies
234
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,236 (88.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$530 (11.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$424
2023
$981
2022
$725
2021
$723
2020
$410
2019
$512
2018
$991

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$81
Astellas Pharma US Inc
$60
Genentech USA, Inc.
$32
Merck Sharp & Dohme LLC
$28
JAZZ PHARMACEUTICALS INC.
$27
Exelixis Inc.
$24
Daiichi Sankyo Inc.
$23
PFIZER INC.
$22
Karyopharm Therapeutics Inc.
$21
Regeneron Healthcare Solutions, Inc.
$21
PharmaEssentia USA Corporation
$19
Alexion Pharmaceuticals, Inc.
$19
Incyte Corporation
$17
Stemline Therapeutics Inc.
$17
Tempus AI, Inc
$15
Top 3 companies account for 40.6% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$508
Amgen Inc.
$465
Janssen Biotech, Inc.
$239
Myriad Genetic Laboratories, Inc.
$238
Pharmacyclics LLC, An AbbVie Company
$235
Jazz Pharmaceuticals Inc.
$232
Seagen Inc.
$202
Celgene Corporation
$201
E.R. Squibb & Sons, L.L.C.
$191
PFIZER INC.
$184
Merck Sharp & Dohme Corporation
$175
Daiichi Sankyo Inc.
$151
Genentech USA, Inc.
$145
TESARO, Inc.
$134
Merck Sharp & Dohme LLC
$128
Takeda Pharmaceuticals U.S.A., Inc.
$111
Incyte Corporation
$102
AstraZeneca Pharmaceuticals LP
$90
Regeneron Healthcare Solutions, Inc.
$66
Astellas Pharma US Inc
$60
Myovant Sciences Inc.
$60
EMD Serono, Inc.
$55
Lilly USA, LLC
$48
Gilead Sciences, Inc.
$45
AMAG Pharmaceuticals, Inc.
$42
PharmaEssentia USA Corporation
$40
Coherus Biosciences Inc.
$40
TAIHO ONCOLOGY, INC.
$39
Stemline Therapeutics Inc.
$38
Exelixis Inc.
$36
ARRAY BIOPHARMA INC
$34
AVEO Pharmaceuticals, Inc.
$34
Rigel Pharmaceuticals, Inc.
$32
MorphoSys, US Inc.
$31
Alexion Pharmaceuticals, Inc.
$31
Taiho Oncology, Inc.
$27
JAZZ PHARMACEUTICALS INC.
$27
Puma Biotechnology, Inc.
$25
GlaxoSmithKline, LLC.
$22
Alnylam Pharmaceuticals Inc.
$22
Karyopharm Therapeutics Inc.
$21
Sobi, Inc
$18
Eisai Inc.
$18
Foundation Medicine, Inc.
$16
Horizon Therapeutics plc
$15
ACCORD HEALTHCARE, INC.
$15
Tempus AI, Inc
$15
Agios Pharmaceuticals, Inc.
$13
Dova Pharmaceuticals
$13
Mylan Institutional Inc.
$13
Kite Pharma, Inc.
$12
Teva Pharmaceuticals USA, Inc.
$11
Top 3 companies account for 25.4% of all-time payments
Associated products mentioned in payments ›
Abraxane · Alecensa · Avastin · BENDEKA · BESREMI · BRAFTOVI · Bavencio · CABOMETYX · CAMCEVI · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ENHERTU · ERLEADA · Enhertu · Erleada · FERAHEME · FOTIVDA · GAZYVA · GIVLAARI · IBRANCE · ICLUSIG · IDHIFA · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · Itovebi · JAKAFI · KANJINTI · KEYTRUDA · KISQALI · KRYSTEXXA · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MVASI · MYRISK · NINLARO · Nerlynx · Neulasta · Nplate · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Ogivri · Orserdu · PADCEV · PIQRAY · PROMACTA · Pomalyst · REBLOZYL · RYDAPT · Revlimid · SANDOSTATIN LAR · SHINGRIX · SUTENT · TAGRISSO · TASIGNA · TECVAYLI · TUKYSA · Tavalisse · Trodelvy · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · VYXEOS · Venclexta · Vyloy · XPOVIO · XTANDI · ZEJULA · ZEPZELCA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (89%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a hematology & oncology specialist in Gallipolis?
Compare hematology & oncology specialists in the Gallipolis area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
1
Per 100K population
3.4
County median income
$56,455
Nearest hospital
HOLZER MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Bhanja is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Bhanja experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Bhanja performed 48 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bhanja receive payments from pharmaceutical companies?
Yes. Dr. Bhanja received a total of $4,766 from 52 companies across 234 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bhanja's costs compare to other hematology & oncology specialists in Gallipolis?
Dr. Bhanja's average Medicare payment per service is $99. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bhanja) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →